China Resources Medical H1 2025 net profit declines 26.9%

China Resources Medical Holdings Company Limited reported a net profit of RMB374 million for the first half of 2025, a 26.9% decrease from RMB511.655 million in the corresponding period of 2024. Total revenue also fell by 9.1% to RMB4,524.803 million from RMB4,976.334 million. The hospital business segment's revenue decreased by 7.4% to RMB4,259 million, impacted by a 5.8% drop in average medical insurance fees per visit. Segment gross profit for the hospital business was RMB670 million, down 27.4%, with a gross profit margin of 15.7%.

Other business revenue declined by 29.3% to RMB266 million. However, segment profit for other business increased by 96.9% to RMB292 million, largely due to a one-off compensation of RMB210 million from the Yan Hua IOT Agreement. Excluding this compensation and related enterprise income tax, the net profit would have decreased by 57.1% year-over-year. The company's total assets stood at RMB13,585,629 million as of June 30, 2025, with cash and cash equivalents at RMB1,194,647 million.

An interim dividend of RMB5 cents per share has been declared for the six months ended June 30, 2025, payable on October 24, 2025. The company will continue to focus on patient-centered services, disciplinary brand building, and exploration of non-insurance-covered and "medical + Internet" businesses.